Search Browse Earnings

LENZ Therapeutics, Inc.

Nasdaq:LENZ

Biological Products, (No Diagnostic Substances)·SOLANA BEACH, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Schimmelpennink Evert B.

CFO

Chevallard Daniel R.

Revenue

—

Adj. EBITDA

-$72.4M

FY 2024

Net Income

-$70.0M

FY 2024

EPS (Diluted)

-$35.71

FY 2024

Stock Price

$11.46

-4.1%

2026-03-12

52W Range

$11.21 – $50.40

P/E Ratio

-0.3x

Market Cap

$358.4M

Cash

$35.1M

FY 2024

Total Debt

—

Net Cash

$35.1M

Enterprise Value

$323.3M

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

-4.5x

Employees

—